All regions

Europe

Latvia	Central office of JSC «Grindeks» is located in the capital of Latvia, Riga, ensuring processes of the concern monitoring, governance and management. Manufacturing units of «Grindeks» active pharmaceutical ingredients, final dosage forms, capsules and syrups is located in Riga. Read more
Lithuania	Representative office of JSC «Grindeks» in Lithuania was opened in 1997; affiliate of «Grindeks» was developed in 2005. Read more
Estonia	«Grindeks» subsidiary company “Tallinn pharmaceutical plant”, where ointments are produced, is located in Estonia. Read more
Belarus	Representative office of JSC «Grindeks» operates in Belarus since January 2002. The main duty of the office is sales and distribution of the products in the local market, securing the stable cooperation with the main wholesalers and performing activities for the awareness rising of «Grindeks» brand, as well as ensuring the registration process of «Grindeks» medications in Belarus. Read more
Russia	Russia is one of the biggest realization markets of «Grindeks», one third of the final dosage medications of «Grindeks» were exported to Russia in 2005. Since 2001, «Grindeks» is also exporting active pharmaceutical ingredients (Oxytocine and Droperidol) to Russia. Read more
Ukraine	Representative office of JSC «Grindeks» operates in Ukraine since August 2005. The main task of it is to ensure registration process of «Grindeks» products in Ukraine, sales and distribution of medications in the local market, while securing stable cooperation with the main wholesalers and performing activities for the awareness rising of «Grindeks» brand. Read more
Moldova	Representative office of JSC «Grindeks» operates in Moldova since February 2006. The main task of it is to ensure registration process of «Grindeks» products in Moldova, sales and distribution of medications in the local market, while securing stable cooperation with the main wholesalers and performing activities for the awareness rising of «Grindeks» brand. Read more
Poland	JSC «Grindeks» has entered into agreement of registration and cooperation with the Polish company ELJOT that is authorised to represent interests of «Grindeks» in Poland. ELJOT deals with the registration of «Grindeks» products, marketing and sales, as well as solves different issues and uncertainties. Products that are being exported to Poland are ointment Viprosal® and injections of Oxytocine. Read more
Czech Republic	«Grindeks» has entered into an agreement of registration and cooperation with the company of Czech Republic K+K Pharma that is authorised to represent interests of «Grindeks» in Czech Republic. K+K Pharma deals with the registration, sales and marketing of «Grindeks» products. «Grindeks» in Czech Republic is selling capsules of the brand product Ftorafur®. Read more
Hungary	«Grindeks» has entered into registration and cooperation agreement with the Hungarian company Medi-Zone,Kft, that is authorised to represent interests of «Grindeks» in Hungary. Medi-Zone,Kft deals with the registration, sales and marketing of «Grindeks» products. «Grindeks» in Hungary is selling capsules of the brand product Ftorafur®. Read more
Finland	In 2004 JSC «Grindeks»entered into the sales agreement with the Finnish chain of pharmacies Scanpharma, as well as started registration of certain products in Finland – Zopiclone, Paraceptamol, Aspirin, Ibuprofen, Loperamid. Cooperation with Finland is developed since 2004. Active pharmaceutical ingredient Zopiclone is being exported to Finland. Read more
Germany	JSC «Grindeks» has stable and continuous cooperation with the company Merck Group; its headquarters are located in Germany. Read more
Austria	JSC «Grindeks» exports and sells active pharmaceutical ingredient Oxytocine to the Austrian market. Read more
Switzerland	Cooperation of JSC «Grindeks» with Switzerland started in 2001. «Grindeks» is exporting active pharmaceutical ingredients Oxytocine and Droperidol to Switzerland. Read more
Bulgaria	JSC «Grindeks» has entered into the agreement of registration and cooperation with the Bulgarian company Sopharm on the registration and distribution of «Grindeks» products Mildronate® (capsules in injections), Ftorafur®, Venlafaksin, Somnol® and Riperoidon. Since 2001 active pharmaceutical ingredient Oxytocine is being exported and sold in Bulgaria. Read more
Belgium	In 2006 JSC «Grindeks» started cooperation with the Belgium company Pagan. «Grindeks» is exporting active pharmaceutical ingredient Droperidol to Belgium. Read more
Denmark	Since 2001, JSC «Grindeks» started active participation in Danish market. «Grindeks» exports active pharmaceutical ingredient Oxytocine to Denmark. «Grindeks» started cooperation with the Danish company Polypeptide Laboratories for the purpose of selling active pharmaceutical ingredients in 2004. Read more
Netherland	Since 2001, JSC «Grindeks» started cooperation with the Netherlands. Company is exporting active pharmaceutical ingredients Oxytocine, Droperidol, Citarabin to the Netherlands. In 2005 «Grindeks» started cooperation with the Dutch company Eurovet Animal health on the development of new products (substances) to the veterinary market. Read more
France	JSC «Grindeks» started cooperation with France in 2001. Company exports active pharmaceutical ingredients – Oxytocine, Droperidol and Rilmenidine to France. Along with the sales of active pharmaceutical ingredients «Grindeks» has developed successful cooperation with the company Merck Generiques (part of the Merck Group) in terms of the research, development and selling of substances to the French market. Read more
Spain	Since 2001, JSC «Grindeks» exports and sells active pharmaceutical ingredient Oxytocine to Spanish market. Read more
Great Britan	JSC «Grindeks» started to export substances to Great Britain in 2001; every year the export volume is increasing. Read more
Ireland	JSC «Grindeks» started cooperation with Ireland in 2001 by exporting active pharmaceutical ingredient Zopiclone. Read more
Italy	JSC «Grindeks» exports and sells active pharmaceutical ingredient Oxytocine to the Iltalian market. Read more
Sweden	Cooperation of «Grindeks» with Sweden started in 2009. This cooperation began with the delivery of an active pharmaceutical ingredient Oxytocin. Read more

Asia

Azerbaijan	Representative office of JSC «Grindeks» operates in Azerbaijan since September 2007. Read more
Georgia	Representative office of JSC «Grindeks» operates in Georgia since April 2006. Main task of the representative office is to ensure registration process of «Grindeks» products in this country, sales and distribution of medications in the local market while securing stable cooperation with the main wholesalers and performing activities for the awareness rising of «Grindeks» brand. Read more
India	JSC «Grindeks» exports active pharmaceutical ingredient Oxytocine to India. Since 2002, the cooperation with the Indian conciliator has successfully developed and improved. Read more
Japan	In 1965 «Grindeks» started cooperation with the Japanese companies “Taiho Pharmaceutical” and “Iskra Industry”, but in 1972 company entered into agreement on the supply of the «Grindeks» brand product, anti-cancer agent Ftorafur® to the Japanese market. Read more
Kazakhstan	Representative office of JSC «Grindeks» operates in Kazakhstan since July 2002. Main task of the representative office is to ensure registration process of «Grindeks» products in Kazakhstan, sales and distribution of medications in the local market while securing stable cooperation with the main wholesalers and performing activities for the awareness rising of «Grindeks» brand. Read more
Vietnam	«Grindeks» began the export of active pharmaceutical ingredient Zopiclone to Vietnam in 2010. Read more
Pakistan	JSC «Grindeks» exports active pharmaceutical ingredient Oxytocine to this country with a specialization for veterinary market, where this substance is mostly used in animal breeding and enhancement of milk productivity. Read more
Singapore	JSC «Grindeks» exports active pharmaceutical ingredient Oxytocine to Singapore. Read more
Taiwan	Since 2001, JSC «Grindeks» exports active pharmaceutical ingredient Oxytocine to Taiwan. Read more
Thailand	Since 2001, JSC «Grindeks» exports active pharmaceutical ingredient Oxytocine to Thailand. Read more
Uzbekistan	«Grindeks» opened representative office in Uzbekistan in April 2008. Read more
Iran	JSC «Grindeks» has entered into the agreement of registration and cooperation with the Iranian company Abadis Chem on manufacturing, registration and sales of the medications Digoksin and Varfarin to this region. Read more
Armenia	Representative office of JSC «Grindeks» operates in Armenia since July 2012. Read more
Turkey	«Grindeks» has exported Oxytocin, an active pharmaceutical ingredient, to Turkey for several years. Read more
Tajikistan
Kyrgyzstan
Indonesia	«Grindeks» is exporting Oxytocin, an active pharmaceutical ingredient, to Indonesia. Read more
Malaysia	«Grindeks» is exporting Oxytocin, an active pharmaceutical ingredient, to Malaysia. Read more
China	Since 2003, JSC «Grindeks» exports active pharmaceutical ingredient Oxytocine to China. Read more

Africa

South Africa	JSC «Grindeks» exports active pharmaceutical ingredient Oxytocine to South Africa. Read more
Egypt	JSC «Grindeks» exports active pharmaceutical ingredient Oxytocine to Egypt. Read more

South America

Argentina	Since 2004, JSC «Grindeks» exports and sells active pharmaceutical ingredient Oxytocine to Argentina. Read more
Brazil	JSC «Grindeks» is exporting Oxytocin, an active pharmaceutical ingredient, to Brazil. Read more
Chile	For several years «Grindeks», in cooperation with the agent's firm “Cobilux”, is exporting active pharmaceutical ingredients Oxytocin and Droperidol to Chile. Read more
Bolivia	JSC «Grindeks» is exporting Oxytocin, an active pharmaceutical ingredient, to Bolivia. Read more

North America

USA	JSC «Grindeks» exports active pharmaceutical ingredient Oxytocine to the USA under the exclusivity agreement with the company GDL International. Cooperation with this company is developed with the aim of research, development and manufacturing of active substances for the veterinary market. Read more
Mexico	Since 2010 JSC «Grindeks» is exporting active pharmaceutical ingredient Xylazine to Mexico. Read more
Canada	JSC «Grindeks» started cooperation with Canada in 2004. «Grindeks» exports active pharmaceutical ingredients Oxytocine, Droperidol and Xylazine to Canada. Read more

Central America

Guatemala

JSC «Grindeks» is exporting active pharmaceutical ingredient Oxytocin to Guatemala.
Read more

Australia and Oceania

Australia

JSC «Grindeks» exports active pharmaceutical ingredient Oxytocine to Australia. The company has started the cooperation with the Australian company Ranvet on distribution and sales of the new substance for veterinary market to Australia.
Read more